Cerebrolysin in Critically Ill Patients With Delirium

Patients were randomized into two groups: CBL - patients treated with cerebrolysin at the daily dose of 50 mL, and K - control patients treated without cerebrolysin. Cerebrolysin was administrated intravenously on the day the delirium was detected and then for seven consecutive days.

Patients enrolled in group K received the infusion of 0.9% Saline solution at a volume of 250 mL.